The EverGo Portable Oxygen Concentrator

EverGo is part of the Freedom Series of oxygen therapy products – an entire family of products designed to deliver clinically superior treatment and more freedom from worry, freedom from deliveries, freedom from complicated maintenance. In short, the EverGo frees you from some of the more demanding aspects of oxygen therapy, so you can go on with your life.

Oxygen Delivery That You and Your Patients can rely on

EverGo combines pulse dose breath detection technology based on 12 milliliters time the setting prescribed of oxygen to make sure even the most active patients get the right amount of oxygen. It detects the onset of inspiration and delivers a measured dose of oxygen when it is needed.

Larger Oxygen Capacity Lets Active Patients Stay Active

EverGo delivers 1050 ml/min of oxygen through fixed bolus delivery, increasing the amount of oxygen with each setting. That means you have the access to more oxygen with each breath – and you have a much lower chance of out-breathing the device.

8 Hour Setting 2 Means More Freedom for You

EverGo is the portable oxygen therapy solution that truly gives the most active patients the freedom they deserve. Its extra-long battery life gives them the freedom to be spontaneous, and its larger oxygen capacity means patients can test thier limits- without being limited by the device.

FAA Clearance / Airline Approved

When you don’t need to wait at home for oxygen deliveries, you are free to explore your world. And EverGo gives you much more world to discover. Weighing less than 8 pounds, and cleared for air travel by the FAA, EverGo is ideally suited for patients who are active and love to travel. That leaves you free to go whereever you want whenever you want.

About Philips Respironics

Respironics is the leading provider of innovative solutions for the global sleep and respiratory markets. The Company’s success spans more than three decades and can be traced to a history deeply rooted in ingenuity and a passion to deliver solutions to those in need. This tradition of innovation, combined with an ability to anticipate market needs, is fundamental to the Company. It has made Respironics a name acknowledged worldwide as a pace-setter in the sleep and respiratory markets.

Respironics’ success can be attributed, in part, to its ability to anticipate the needs of the markets it serves, and to provide a range of solutions to address market challenges. Known for expertise in its core areas of sleep and respiratory, the Company is aggressive in its cultivation of promising opportunities such as
delivering drugs via the respiratory pathway, seeking methods to assist “problem sleepers” and evolving educational programs to help caregivers in the Neonatal
Intensive Care to nurture premature and ill newborns.

Respironics is organized into three primary groups: the Sleep and Home Respiratory Group, the Hospital Group, and the International Group. This decentralized business structure helps to ensure that the Company’s resources are channeled to efficiently meet specific market needs. Each group also has a comprehensive
understanding of their markets—from present day healthcare business challenges to future opportunities for emerging technologies and exploration beyond
traditional sleep and respiratory markets.